Key facts
- Notable investors include Royal Sunward Capital, Zhangjiagang Jinmao Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Meishangjie
- ·The full record, as it builds
Funding rounds
No funding rounds for Meishangjie are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Meishangjie
Provider of anti-aging skin care products designed to operate in the field of genetic engineering and synthetic biotechnology. The company's anti-aging skincare products and Class II medical devices provide R&D and clinical testing in the field of Class III medical devices, providing service and products are widely used in medical aesthetics, burn treatment, surgery, ophthalmology, and other medical fields.
- Sector
- Healthcare
- HQ
- Zhangjiagang, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Meishangjie doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Meishangjie shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Meishangjie in its N-PORT filings yet. We sweep new filings monthly.